MediSapiens Supports Bayer’s Future Clinical Trial Program (Updated)

MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others.

To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials program in more detail in the Business Finland Health Tuesday event from 5:30 to 23:30 here  or see Bayer’s press release.

Share this article: